Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Zymeworks’ HER2 Bispecific Under Review in China for Rare HER2 Cancers

publication date: Jun 10, 2024

Vancouver’s Zymeworks announced that its BLA for zanidatamab, a HER2-targeted bispecific antibody, was accepted for review by China’s CDE as a second-line treatment for HER2-positive biliary tract cancer (BTC). Zanidatamab can simultaneously bind two non-overlapping epitopes of the HER2 receptor, known as biparatopic binding. In 2018, BeiGene acquired Asia Pacific rights to zanidatamab and several other Zymeworks candidates in a $1.1 billion agreement. Following a Phase IIb trial, Zymeworks and BeiGene filed the BLA, which triggered an $8 million milestone from to Zymeworks. More details....

Stock Symbol: (NSDQ: ZYME)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here